2013 - CTS 2013 Congress

This page contains exclusive content for the member of the following sections: TTS, CTS

Plenary: Mesenchymal stem cells in regenerative medicine: opportunities and challenges

25.2 - Improving Mesenchymal Progenitors Transplantation in Cellular Therapies

Presenter: Massimo, Dominici, Modena, Italy
Authors: Massimo Dominici

While multipotent mesenchymal stromal cells (MSC) have been introduced into pre-clinical and clinical studies since the far sixties, their full potentials to regenerate tissues have been partially clarified. We retain several aspects shall be considered and improved to generate optimized regenerative potentials by MSC in humans. In this paper, starting from in vivo detection of MSC, we will describe technologies and models that in our hands allow: (1) to ex-vivo isolate and characterize MSC for clinical applications, (2) to assess their in vitro potency to regenerate tissues, (3) to create pre-clinical in vivo rational for their clinical implementation and, (4) to establish protocols for their delivery. The attempt to standardize these aspects for a specific clinical indication is an essential prerequisite to better define and challenge MSC biological properties. This applies particularly in case of multi-centric tissue regeneration studies, as is currently taking place in the REBORNE consortium sponsored by the FP7.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory
This email address is being protected from spambots. You need JavaScript enabled to view it.


The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7